A 6-month prospective randomized controlled trial of remotely delivered group format epilepsy self-management versus waitlist control for high-risk people with epilepsy.

Jennifer B LevinKari Colon-ZimmermannMustafa KahrimanEdna Fuentes-CasianoHongyan LiuCurtis TatsuokaKristin A CassidySamden D LhatooDouglas EinstadterPeijun Chen

Published in: Epilepsia (2018)

SMART is associated with reduced health complications and improved mood, quality of life, and health functioning in high-risk people with epilepsy. Additional efforts are needed to investigate potential for scale-up.

Keyphrases

randomized controlled trial
public health
healthcare
mental health
human health
health information
study protocol
bipolar disorder
health promotion
risk assessment
temporal lobe epilepsy
climate change
sleep quality
depressive symptoms
social media